Roche cuts ties with Atea after COVID-19 pill’s trial failure
Roche's seeming lack of confidence in the future of AT-527 appears to be weighing on investors. Atea shares, which soared above $88 in February 2021, dropped 20% to b...
Mastering ADC Bioconjugation: From DAR Control to Efficient Free Payload Removal
Continue readingAdvertisement
Advertisement
Advertisement
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.